Haplotype analysis revealed statistically-significant increased risk of breast cancer with ERCC6 Hap 2 (OR 1.36, 95% CI 1.03–1.78, p = 0.03) (Supplementary Table 4). Here, ERCC6 is linked to breast carcinoma.